| SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans. | |
| | |
MedLine Citation:
|
PMID: 15080855 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The administration of exogenous neurotensin can reduce the lower oesophageal sphincter pressure, but it is unclear whether this effect is pharmacological or physiological. AIM: A specific neurotensin receptor antagonist (SR 48692) was used to assess the effect of endogenous neurotensin on lower oesophageal sphincter function. METHODS: Twenty-four healthy male subjects were included in a double-blind, placebo-controlled, randomized, cross-over study designed to determine the effects of two single doses (90 and 300 mg, preceded by a loading dose) of SR 48692 on the resting lower oesophageal sphincter pressure, transient lower oesophageal sphincter relaxations, primary oesophageal peristalsis and oesophageal acid exposure. Oesophageal pH and motility recordings were performed during 1 h of fasting and 3 h post-prandially. Plasma neurotensin-like immunoreactivity release was determined by radioimmunoassay. RESULTS: During fasting, the lower oesophageal sphincter pressure, transient lower oesophageal sphincter relaxation rate and reflux episodes were similar with the two doses of SR 48692 and placebo. Meal ingestion induced a rise in plasma neurotensin-like immunoreactivity, a decrease in lower oesophageal sphincter pressure and an increase in both the transient lower oesophageal sphincter relaxation rate and the number of reflux episodes, which were not significantly modified by SR 48692. SR 48692 did not affect oesophageal primary peristalsis. CONCLUSION: This study shows that SR 48692, a specific neurotensin 1 receptor antagonist, has no effect on oesophageal motility in humans. |
| | |
Authors:
|
F Zerbib; T Piche; F Charles; J-P Galmiche; S Bruley des Varannes |
Related Documents
:
|
7212405 - Esophageal and intrapleural pressures in the healthy conscious pony. 5937415 - The effects of pressure and pharmacologically active substances on gastric peristalsis ... 6848055 - The angelchik antireflux prosthesis. effects on the lower esophageal sphincter of prima... 2301575 - The propulsive behavior of the opossum sphincter of oddi. 14498915 - Colloid osmotic pressure after hemorrhage and replenishment with oxyglobin solution, he... 3722075 - Measurement of capillary pressure in humans using a venous occlusion method. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Alimentary pharmacology & therapeutics Volume: 19 ISSN: 0269-2813 ISO Abbreviation: Aliment. Pharmacol. Ther. Publication Date: 2004 Apr |
Date Detail:
|
Created Date: 2004-04-14 Completed Date: 2004-07-20 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8707234 Medline TA: Aliment Pharmacol Ther Country: England |
Other Details:
|
Languages: eng Pagination: 931-9 Citation Subset: IM |
Affiliation:
|
INSERM U539 and Centre d'Investigation Clinique INSERM, Department of Gastroenterology and Hepatology, University of Nantes, Nantes, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Esophagogastric Junction / drug effects Esophagus / drug effects* Gastrointestinal Motility / drug effects* Humans Hydrogen-Ion Concentration Male Peristalsis / drug effects Pyrazoles / pharmacokinetics, pharmacology* Quinolines / pharmacokinetics, pharmacology* Receptors, Neurotensin / antagonists & inhibitors* |
| Chemical | |
Reg. No./Substance:
|
0/Pyrazoles; 0/Quinolines; 0/Receptors, Neurotensin; 146362-70-1/SR 48692 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pyl...
Next Document: Restless legs syndrome: an overview of the current understanding and management.